Product Information

ENALAPRIL MALEATE 5 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.0845 per EA under NDC 51672403803. Its NADAC has been published 604 times since Apr 1, 2015.

FDA first approved this application on Jan 23, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENALAPRIL MALEATE 5 MG TABLET

Enalapril Maleate
$0.0845per EA

Strength

5 mg/1

NDC

51672403803

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ENALAPRIL MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA075657

FDA Approved

1/23/2001

TE Code

AB

On Market Since

1/23/2001

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure

Price Statistics

The NADAC for ENALAPRIL MALEATE 5 MG TABLET has been published 604 times since Apr 1, 2015, and over the history we have for it it has declined 76.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0845 per EA
All-time high$0.3806 (Jul 15, 2015)
All-time low$0.0693 (May 22, 2024)
52-week high$0.0845
52-week low$0.0709
Median price$0.1691
Average price$0.1760
Largest weekly change+58.6% (Apr 19, 2023)
Weeks tracked604
Tracking sinceApr 1, 2015

Price History

1W

0.0%

1M

+16.7%

3M

+11.6%

6M

+14.9%

1Y

+10.5%

3Y

-0.1%

5Y

-42.9%

All

-76.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENALAPRIL MALEATE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 5 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.0845 per EA (NDC 51672403803), effective Nov 11, 2026.

How has the price of ENALAPRIL MALEATE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has declined 76.9%. It has been tracked across 604 weekly CMS publications since Apr 1, 2015.

What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 5 MG TABLET?

Since Apr 1, 2015, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has ranged from a low of $0.0693 (May 22, 2024) to a high of $0.3806 (Jul 15, 2015), with a median of $0.1691 per EA.

Are there cheaper alternatives to ENALAPRIL MALEATE 5 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENALAPRIL MALEATE 5 MG TABLET, is $0.0819 per EA — about 3% below ENALAPRIL MALEATE 5 MG TABLET.

Who manufactures ENALAPRIL MALEATE 5 MG TABLET?

ENALAPRIL MALEATE 5 MG TABLET (NDC 51672403803) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.